tiprankstipranks
Trending News
More News >
Compass Therapeutics (CMPX)
NASDAQ:CMPX
US Market

Compare Compass Therapeutics (CMPX) vs. Competitors

Compare
456 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Compass Therapeutics
$6.38
$1.10B
-13.94
105.14%
8 Buy
0 Hold
0 Sell
Strong Buy
KalVista Pharmaceuticals
$15.65
$765.27M
-3.91
78.45%
8 Buy
0 Hold
0 Sell
Strong Buy
CytomX Therapeutics
$5.90
$999.67M
13.73
600.00%
6 Buy
0 Hold
0 Sell
Strong Buy
Gossamer Bio
$2.42
$590.21M
-3.52
163.62%
4 Buy
1 Hold
0 Sell
Strong Buy
Bicycle Therapeutics
$6.52
$456.44M
-1.80
-49.77%
5 Buy
2 Hold
0 Sell
Moderate Buy
Monopar Therapeutics Inc
$67.34
$450.64M
-19.58
73.56%
11 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CMPX
Compass Therapeutics
6.38
3.36
111.26%
KALV
KalVista Pharmaceuticals
15.65
6.88
78.45%
CTMX
CytomX Therapeutics
5.74
4.86
552.27%
GOSS
Gossamer Bio
2.42
1.46
152.08%
BCYC
Bicycle Therapeutics
6.52
-6.25
-48.94%
MNPR
Monopar Therapeutics Inc
67.34
24.84
58.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts